Low dose allergen therapy (LDA) is a method of immunotherapy that involves desensitization with combinations of low dose allergens coupled with an enzyme mixture. This is not regulated by the FDA as it is compounded under specific directions from a compounding pharmacy. Therefore, LDA is not a covered benefit by health insurance. It is legal to use LDA as long as it is prescribed properly and used according to the specific protocol. LDA can be used for both inhalant allergies and food allergies. There has never been a reported case of a fatality or life-threatening system reaction.
LDA is initially given at two month intervals for the first year. Afterwards, the LDA is administered at three month intervals. In order for LDA to work, a very specific and rigid protocol involving diet and drugs must be followed or the LDA will not be successful.
PATIENTS ARE INSTRUCTED NOT TO INITIATE LDA THERAPY UNLESS THEY ARE WILLING TO BE TREATED FOR AT LEAST 12 MONTHS (SIX INJECTIONS) AND FOLLOW THE RIGID PROTOCOLS BEFORE NOTICING ANY RELIEF OF THE ALLERGIC SYMPTOMS. PATIENTS ARE ALSO REMINDED THAT LDA IS NOT A COVERED BENEFIT BY ANY HEALTH PLANS.